Delfi

3 top consumer picks revealed as RHB expects sector to outperform ST Index in 2019
SINGAPORE (Jan 4): RHB Research is maintaining its “overweight” rating on the Singapore consumer sector, against the backdrop of a global economic slowdown and uncertainty arising from trade tension between the US and China. “We believe the consumer sector will outperform the [Straits Times Index], given its more defensive nature,” says analyst Juliana Cai in a Friday ...
Will Delfi's expected recovery be sweet enough for investors?
SINGAPORE (May 9): RHB Research is keeping its “neutral” rating on Delfi with an unchanged target price of $1.54, even as it anticipates a recovery for the chocolate confectionery company. “Delfi’s efforts to refocus on core brands and invest in its route-to-market capabilities are likely to bear fruit this year,” says analyst Juliana Cai in a Wednesday report. However, she adds ...
Delfi posts 33.1% rise in 1Q earnings to $10.1 mil on higher revenue
SINGAPORE (May 7): Chocolate confectionery company Delfi saw its earnings grow 33.1% to US$7.6 million ($10.1 million) for the 1Q ended March, from US$5.7 million a year ago. 1Q18 revenue rose 15.1% to US$107.3 million, from US$93.3 million a year ago. This was driven mainly by sales of Delfi’s Own Brands products in Indonesia, especially its premium product. In addition, the higher ...
Delfi acquires rights to Van Houten brand in key Asia markets
SINGAPORE (Apr 13): Chocolate confectionery company Delfi is acquiring a perpetual and exclusive license to the Van Houten brand of chocolate and cocoa products from Hershey Singapore, which is part of The Hershey Company, and Barry Callebaut AG for US$13 million ($17 million). Delfi’s wholly owned subsidiary, PT Perusahaan Industri Ceres, has been the sub-licensee for the Van Houten brand ...
Delfi upgraded to 'buy' on sweeter prospects ahead
SINGAPORE (Dec 19): DBS Group Research is upgrading chocolate confectionery company Delfi to “buy”, from “hold” previously, on hopes of a better 2018. “Delfi’s share price is at 6-year low and has slumped by 36% year-to-date on the back of its disappointing performance,” says lead analyst Andy Sim in a Monday report. “Looking ahead, we believe its share price could have priced ...
Delfi seen to be sweeter amid first signs of revenue recovery
SINGAPORE (Nov 15): RHB Research is keeping its “buy” call on chocolate confectionery company Delfi but lowering its target price to $1.65, from $1.86 previously, due to slower-than-expected consumption recovery. “3Q17 results have shown the first signs of recovery in terms of revenue growth in local currencies,” says analyst Juliana Cai. In particular, its core brands demonstrated ...
How Singapore’s biggest listed F&B producers have sought to break the mould
SINGAPORE (Sept 4): Singapore is well-positioned to serve integrated networks in the F&B manufacturing and processing industry, in addition to enabling capital formation through its stock market, according to Singapore Exchange (SGX) market strategist Geoff Howie. In the Aug 30 issue of SGX My Gateway, Howie notes that the largest 10 capitalised stocks listed on the SGX that ...
Delfi 1H earnings fall 10% to US$14.9 mil on lower revenue
SINGAPORE (Aug 7): Chocolate confectionery company Delfi posts earnings of US$14.9 million ($20.3 million) for the 1H ended June, falling 10.0% from US$16.6 million a year ago. Earnings in 2Q climbed 14.4% to US$9.3 million, from US$8.1 million a year ago. However, this was including an exceptional gain of US$4.4 million arising from the disposal of the group’s 50% stake in its associate PT ...
Delfi 1Q earnings fall 33% to US$5.6 mil
SINGAPORE (May 8): Delfi, the distributor of chocolate confectionery products, posted a 33.4% decline in earnings to US$5.6 million ($7.9 million) in the first quarter ended March, from US$8.4 million a year ago. This was partially due to a higher effective tax rate on the back of higher withholding tax paid on dividend and royalty income received from the group’s subsidiaries in ...
Raffles Medical, Nam Cheong, GL, CRCT, Keong Hong, Delfi, ISR, Healthway Medical
SINGAPORE (April 24): Here are some stocks that could move the market this Monday morning: Raffles Medical Group posted relatively flat 1Q earnings of $15.5 million, just 0.1% higher than a year ago. Revenue for the 1Q17 ended March, fell 1.7% to $114.9 million. Shares of Raffles Medical closed 1 cent lower at $1.42. See: Raffles Medical 1Q earnings stay flat at $15.5 mil Nam Cheong, the ...